BIOMAT Database Logo BIOMAT Database Logo

Severe anaphylaxis from rifamycin SV. 1998

F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
Department of Allergy, Gülhane Military Medical Academy, Ankara, Turkey.

BACKGROUND Anaphylaxis to topical application of rifamycin SV, which is used topically in the fields of surgery and dermatology, is rare. METHODS We report two cases of systemic reactions occurring after local administration of rifamycin (Rifocine, Gruppo Lepetit, Italy). Both of them needed repeated intermittent topical applications. Skin prick tests with Rifocine constituents were performed on our patients, and also on ten atopic and ten nonatopic subjects. Although an old investigative tool, Prausnitz-Küstner (P-K) test was also performed on one of the patient's spouses to show passive transfer and the IgE-mediated mechanism. RESULTS Allergy assessment with skin tests on the patients were negative for aeroallergens, latex, and Rifocine constituents (except rifamycin SV). The patients' prick tests with rifamycin SV were positive, and the control subjects were negative. P-K testing was positive. CONCLUSIONS Two case reports support the existence of IgE-mediated reactions to rifamycin SV. IgE-mediated anaphylactic reactions from rifamycin SV appear to be extremely rare.

UI MeSH Term Description Entries
D007428 Intradermal Tests Skin tests in which the sensitizer is injected. Passive Transfer Test,Prausnitz-Kustner Test,Intradermal Test,Passive Transfer Tests,Prausnitz Kustner Test,Test, Intradermal,Test, Passive Transfer,Test, Prausnitz-Kustner,Tests, Intradermal,Tests, Passive Transfer
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid
D012294 Rifamycins A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei. Rifamycin,Rifomycin,Rifomycins
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D013530 Surgical Wound Infection Infection occurring at the site of a surgical incision. Postoperative Wound Infection,Infection, Postoperative Wound,Infection, Surgical Wound,Surgical Site Infection,Wound Infection, Postoperative,Wound Infection, Surgical,Infection, Surgical Site,Infections, Postoperative Wound,Infections, Surgical Site,Infections, Surgical Wound,Postoperative Wound Infections,Surgical Site Infections,Surgical Wound Infections,Wound Infections, Postoperative,Wound Infections, Surgical

Related Publications

F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
Contact urticaria and severe anaphylaxis from rifamycin SV.
August 1992, Contact dermatitis,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
Perioperative anaphylaxis from locally applied rifamycin SV and latex.
June 2006, British journal of anaesthesia,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
Rifamycin SV. A review.
August 1965, Arzneimittel-Forschung,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
[Rifamycin SV in tuberculosis].
March 1963, Archivio di tisiologia e delle malattie dell'apparato respiratorio,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
[EXPERIMENTS WITH RIFAMYCIN SV].
January 1963, Chemotherapia,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
[CLINICAL EXPERIENCE WITH RIFAMYCIN SV].
June 1963, The Journal of antibiotics. Ser. B,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
[Rifamycin SV in endocavitary aspiration].
March 1963, Archivio di tisiologia e delle malattie dell'apparato respiratorio,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
[OUR EXPERIENCE WITH RIFAMYCIN SV].
January 1963, Chemotherapia,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
[PRELIMINARY STUDIES ON RIFAMYCIN SV].
January 1963, Chemotherapia,
F Erel, and M Karaayvaz, and M Deveci, and N Ozangüç
Rifamycin SV and related ansamycins.
January 1995, Biotechnology (Reading, Mass.),
Copied contents to your clipboard!